Cooley LLP
Compositions, methods and kits for diagnosis of lung cancer
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).
Integrated Diagnostics, Inc.
G G G G G G
G01N G16B G16B G01N G01N G16B
additional additional inventional inventional inventional additional
Clive Kenneth Charles Paul Edward Xiao-Jun
Hayward Fang Kearney Li